1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, March 2015 (p20)

Therapy Analysis & Statistics, March 2015 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

571-600 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

Lysosomal Storage Disorder - Pipeline Review, H1 2015

Lysosomal Storage Disorder - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • March 2015
  • by Global Markets Direct

Lysosomal Storage Disorder - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Lysosomal Storage Disorder - Pipeline Review, H1 2015’, provides an overview of the Lysosomal Storage Disorder’s ...

  • Industries : Pathology, Pharmaceutical, Research and Development
  • Countries : United States
Becker Muscular Dystrophy - Pipeline Review, H1 2015

Becker Muscular Dystrophy - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • March 2015
  • by Global Markets Direct

Becker Muscular Dystrophy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Becker Muscular Dystrophy’s ...

  • Industries : Pathology
  • Countries : World, United States
Nabriva Therapeutics AG - Product Pipeline Review - 2015

Nabriva Therapeutics AG - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

Nabriva Therapeutics AG - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Nabriva Therapeutics AG - Product Pipeline Review - 2015’, provides an overview of the Nabriva Therapeutics ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • March 2015
  • by Global Markets Direct

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About Acquired Orphan Blood Diseases Therapeutics Acquired orphan blood diseases are rare disorders and are characterized by the body's inability to produce a sufficient amount of RBCs. This is basically ...

  • Industries : Pathology, Therapy
  • Countries : World
A Competitive Analysis of the Global Breast Cancer Therapeutics Market : A New Class of Targeted Therapeutics Offers Novel Treatment Modalities to Treat Difficult Breast Cancers

A Competitive Analysis of the Global Breast Cancer Therapeutics Market : A New Class of Targeted Therapeutics Offers Novel Treatment Modalities to Treat Difficult Breast Cancers

  • $ 5 000
  • Industry report
  • March 2015
  • by Frost & Sullivan

Executive Summary •The global breast cancer therapeutics market is divided into x segments: hormonal therapy, targeted therapy, chemotherapy, and other therapy (for example, novel drugs in development). ...

  • Industries : Therapy
Endothelial Dysfunction Global Clinical Trials Review, H1, 2015

Endothelial Dysfunction Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • March 2015
  • by Global Data

Endothelial Dysfunction Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Endothelial Dysfunction Global Clinical Trials Review, H1, 2015" provides data on the Endothelial ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Global HER-2 Positive Breast Cancer Market 2015-2019

Global HER-2 Positive Breast Cancer Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Healthcare
  • Countries : World
The US Oncology Network - Strategic SWOT Analysis Review

The US Oncology Network - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2015
  • by Global Data

The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed ...

  • Industries : General Medicine and Specialty Medicine, Therapy, Healthcare
  • Countries : United States
Orion Oyj in Consumer Health (Finland)

Orion Oyj in Consumer Health (Finland)

  • $ 153
  • Company report
  • March 2015
  • by Euromonitor International

Although Orion is seeking growth in all areas of its business, the best opportunities for organic growth, according to the company itself, are seen in its proprietary products. The core therapy areas in ...

  • Countries : Finland
Pharmaceutical Deals and Alliances of 2014

Pharmaceutical Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Pharmaceutical Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Biotechnology Deals and Alliances of 2014

Biotechnology Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Biotechnology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Diagnostics Deals and Alliances of 2014

Diagnostics Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Drug Delivery Deals and Alliances of 2014

Drug Delivery Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Drug Delivery Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Academic/Non-Profit Deals and Alliances of 2014

Academic/Non-Profit Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Academic/Non-Profit Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Generic Pharma Deals and Alliances of 2014

Generic Pharma Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Generic Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Specialty Pharma Deals and Alliances of 2014

Specialty Pharma Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Specialty Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Animal Health Deals and Alliances of 2014

Animal Health Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Animal Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Marketed Stage Deals and Alliances of 2014

Marketed Stage Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Marketed Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Clinical Stage Deals and Alliances of 2014

Clinical Stage Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Clinical Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Pre-Clinical Stage Deals and Alliances of 2014

Pre-Clinical Stage Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Pre-Clinical Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Oncology Deals and Alliances of 2014

Oncology Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Big pharma Deals and Alliances of 2014

Big pharma Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Big Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Nonalcoholic Steatohepatitis: KOL Insight

Nonalcoholic Steatohepatitis: KOL Insight

  • $ 6 495
  • Industry report
  • March 2015
  • by Firstword Pharma

Why This Report is Essential Expect a revolution in the treatment of nonalcoholic steatohepatitis (NASH) as a number of new therapies compete to become the first approved treatment for a disease that ...

  • Industries : Therapy
  • Countries : United States
Myasthenia Gravis Global Clinical Trials Review, H1, 2015

Myasthenia Gravis Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • March 2015
  • by Global Data

Myasthenia Gravis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2015" provides data on the Myasthenia Gravis ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2015

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • March 2015
  • by Global Data

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World
OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021

OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021

  • $ 7 995
  • Industry report
  • March 2015
  • by Global Data

OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 Summary Sepsis patients suffer from a series of diverse complications arising from the presence of pathogens and/or their toxins ...

  • Industries : Pathology, Pharmaceutical
Mirna Therapeutics, Inc. - Product Pipeline Review - 2015

Mirna Therapeutics, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Mirna Therapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Mirna Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Mirna Therapeutics, ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States
Advantagene, Inc. - Product Pipeline Review - 2015

Advantagene, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Advantagene, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Advantagene, Inc. - Product Pipeline Review - 2015’, provides an overview of the Advantagene, Inc.’s pharmaceutical ...

  • Industries : Research and Development, Pathology, Biological Therapy, Therapy, General Medicine and Specialty Medicine
  • Countries : World
Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • February 2015
  • by Global Markets Direct

Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Cutaneous T-Cell Lymphoma’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.